Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Back
  4. Musculoskeletal and Joint Disease
  5. Secondary Fracture Prevention After Hip Fracture for Women 75 and Over (505)
Announcements and latest updates

test announcement

Secondary Fracture Prevention After Hip Fracture for Women 75 and Over (505)

Warning

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient
characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased
susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good
practice to record these and communicate them to others involved in the care of the patient

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 16/07/2019

Next review date: 01/03/2024

Author(s): Colin McCarthy.

Version: 2

Author email(s): colin.mccarthy@ggc.scot.nhs.uk.

Approved By: Medicines Utilisation Subcommittee of ADTC

Reviewer name(s): Colin McCarthy.

Document Id: 505